EFPIA - NEWSLETTER

EFPIA Newsletter 10 April 2025

Pharma CEOs alert President von der Leyen to risk of exodus to the US

CEOs of the research-based pharmaceutical industry issued a stark warning to President von der Leyen that unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US.

Read more here.

Blogs

08 April 2025 The legitimate need of promotion in the pharmaceutical industry (Guest blog)

The pharmaceutical industry's raison d'être is the research and development of new medicines. These innovations are...

The different contributions of the industry in Public-Private Partnerships in Rare Diseases Research continuum

At the core of PPPs lies the recognition that no single sector nor stakeholder has the comprehensive capabilities required to tackle the multifaceted challenges inherent in healthcare research. By strategically combining their respective strengths, public and private entities can collectively achieve outcomes that would be unattainable through individual efforts.

Read the full report here.

Events

15 APR 2025

Vaccines & the EU HTA regulation: Why, what and how? Virtual event

With the EU HTA regulation now in force (January 2025), this session will explore the critical need to account for vaccines...

Learn more →

24 APR 2025

IHI online event on childhood cancer research tools Virtual event

Join to discover the results of the ITCC-P4 public-private partnership.

Learn more →

The conect4children project in action

Discover the conect4children (c4c) project: a large, collaborative pan-European network aiming to optimise the delivery of clinical trials in children.

Watch the video below to learn more about this initiative.

What we are reading

Europe to burned American scientists: We’ll take you in 04 April 2025 (POLITICO)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶